Plus, news about Cullinan, 4DMT, Axsome, AstraZeneca, Noema, UroGen Pharma, Halozyme and Benitec:
↩️ Dyne delays myotonic dystrophy plans again: Dyne said it now expects to submit an application for FDA approval of its ...
↧